This company has shut down. CareSync is no longer operating — its last tracked round was a Series A in 2025.
Explore the Startup GraveyardCareSync is the leading provider of software and services for chronic disease management.
CareSync has raised $650K in total funding. The most recent round was Series A. The last funding was announced in October 2025.
CareSync's investors include Greycroft, Zyptera VC, Clearwell Group, Merck Global Health Innovation Fund, Tullis Health Investors.
CareSync is headquartered in New York, United States.
CareSync is the leading provider of software and services for chronic disease management.
CareSync is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CareSync — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/caresync. Accessed August 15, 2026.
VCBacked. (2025). CareSync — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/caresync
{{cite web |title=CareSync — Funding & Investors |url=https://www.vcbacked.co/company/caresync |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated